MedPath

A population based randomised controlled trial of Helicobacter pylori eradication: impact on dyspepsia, quality of life and health

Completed
Conditions
Dyspepsia
Digestive System
Registration Number
ISRCTN44816925
Lead Sponsor
HS (South and West) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1550
Inclusion Criteria

1. Aged 20 to 59 years, male and female
2. Able to give written informed consent

Exclusion Criteria

Any persons with the following conditions: pregnancy, breast feeding, severe renal impairment, adverse reaction to macrolide antibiotics, concurrent medication with wafarin, theophyllin, digoxin, terfendine, carbemazepine, ergot derivatives, bismuth compounds, acute porphyria.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dyspepsia resolution at two years after randomisation.
Secondary Outcome Measures
NameTimeMethod
1. Reduction in health service utilisation<br>2. Quality of life
© Copyright 2025. All Rights Reserved by MedPath